Bexmarilimab (FP-1305) is a highly potent, humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM, promoting immune conversion of tumor-associated macrophage phenotype M2 to M1, and can be used to study cancer.
Purity:
100.00%
CAS Number:
[2259301-27-2]
Target:
Others
T77379
* VAT and and shipping costs not included. Errors and price changes excepted